1. Institut National De La Sante Et De La Recherche Medicale (23 from 1,743 patents)

2. Université´ D'aix-Marseille (21 from 228 patents)

3. Institut Jean Paoli & Irène Calmettes (17 from 26 patents)

4. Centre National De La Recherche Scientifique (8 from 5,069 patents)

5. Centre Leon Berard (8 from 33 patents)

6. Universite Claude Bernard – Lyon1 (5 from 208 patents)

7. Other (4 from 832,680 patents)

8. Imcheck Therapeutics Sas (4 from 4 patents)

9. Université De Nantes (2 from 141 patents)

10. Centre National De La Recherche Scientifique-cnrs (2 from 65 patents)

11. Inserm (institut National De La Sante Et De La Recherche Medicale) (2 from 36 patents)

12. Eli Lilly and Company (1 from 4,442 patents)

13. Cnrs (1 from 63 patents)

14. Université Claude Bernard (1 from 10 patents)

15. Université De La Méditerranée (1 from 8 patents)

1. 12419964 - Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload

2. 12398206 - Antibodies having specificity for nectin-4 and uses thereof

3. 12258400 - Antibodies having specificity for BTN2 and uses thereof

4. 12247075 - BTN3A binding proteins and uses thereof

5. 12049500 - Anti-nectin-4-antibodies and uses thereof

6. 11987631 - Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

7. 11945871 - Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

8. 11904004 - Anti-CD277 antibodies

9. 11572409 - Antibodies having specificity for BTN2 and uses thereof

10. 11180556 - Antibodies directed against ICOS and uses thereof

11. 10745482 - Antibodies directed against ICOS and uses thereof

12. 10716838 - Anti-CD277 antibodies

13. 10675357 - Antibodies having specificity to nectin-4 and uses thereof

14. 10633446 - Antibodies directed against ICOS and uses thereof

15. 10273306 - Antibodies directed against ICOS for treating graft-versus-host disease